About FSBHI Siberian Clinical Center of the Federal Medical and Biological Agency
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at FSBHI Siberian Clinical Center of the Federal Medical and Biological Agency
During the past decade, FSBHI Siberian Clinical Center of the Federal Medical and Biological Agency conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "FSBHI Siberian Clinical Center of the Federal Medical and Biological Agency"
#1 collaborator was "Chugai Pharmaceutical" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at FSBHI Siberian Clinical Center of the Federal Medical and Biological Agency
According to Clinical.Site data, the most researched conditions in "FSBHI Siberian Clinical Center of the Federal Medical and Biological Agency" are
"Alzheimer Disease" (2 trials), "Multiple Sclerosis" (2 trials), "Generalized Myasthenia Gravis" (1 trials), "Huntingtons Disease" (1 trials) and "Multiple Sclerosis, Primary Progressive" (1 trials). Many other conditions were trialed in "FSBHI Siberian Clinical Center of the Federal Medical and Biological Agency" in a lesser frequency.
Clinical Trials Intervention Types at FSBHI Siberian Clinical Center of the Federal Medical and Biological Agency
Most popular intervention types in "FSBHI Siberian Clinical Center of the Federal Medical and Biological Agency" are "Drug" (8 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Ocrelizumab" (3 trials), "Antihistamine" (2 trials), "Fenebrutinib" (2 trials) and "Gantenerumab" (2 trials). Other intervention names were less common.
Clinical Trials Genders at FSBHI Siberian Clinical Center of the Federal Medical and Biological Agency
The vast majority of trials in "FSBHI Siberian Clinical Center of the Federal Medical and Biological Agency" are
8 trials for "All" genders.
Clinical Trials Status at FSBHI Siberian Clinical Center of the Federal Medical and Biological Agency
Currently, there are NaN active trials in "FSBHI Siberian Clinical Center of the Federal Medical and Biological Agency".
undefined are not yet recruiting,
5 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in FSBHI Siberian Clinical Center of the Federal Medical and Biological Agency,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in FSBHI Siberian Clinical Center of the Federal Medical and Biological Agency, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 8 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".